English | 繁體

Search in the results

UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
Nardoguaianone L Isolated from Nardostachys jatamansi Improved the Effect of Gemcitabine Chemotherapy via Regulating AGE Signaling Pathway in SW1990 Cells Journal article
Zheng, Yi Dan, Ma, Li Mei, Lu, Jin Jian, Chai, Tian, Naghavi, Mohammad Reza, Ma, Jun Yi, Sang, Chun Yan, Yang, Jun Li. Nardoguaianone L Isolated from Nardostachys jatamansi Improved the Effect of Gemcitabine Chemotherapy via Regulating AGE Signaling Pathway in SW1990 Cells[J]. Molecules, 2022, 27(20), 6849.
Authors:  Zheng, Yi Dan;  Ma, Li Mei;  Lu, Jin Jian;  Chai, Tian;  Naghavi, Mohammad Reza; et al.
Favorite | TC[WOS]:3 TC[Scopus]:4  IF:4.2/4.6 | Submit date：2022/11/07
Age-rage Signaling Pathway  Gemcitabine  Pancreatic Cancer  Proteomic  Sw1990 Cells  
Protective effects of Huang-Lian-Jie-Du Decoction on diabetic nephropathy through regulating AGEs/RAGE/Akt/Nrf2 pathway and metabolic profiling in db/db mice Journal article
Tang, Dan, He, Wen Jiao, Zhang, Zhi Tong, Shi, Jing Jing, Wang, Xue, Gu, Wen Ting, Chen, Zhi Quan, Xu, You Hua, Chen, Yun Bo, Wang, Shu Mei. Protective effects of Huang-Lian-Jie-Du Decoction on diabetic nephropathy through regulating AGEs/RAGE/Akt/Nrf2 pathway and metabolic profiling in db/db mice[J]. Phytomedicine, 2022, 95.
Authors:  Tang, Dan;  He, Wen Jiao;  Zhang, Zhi Tong;  Shi, Jing Jing;  Wang, Xue; et al.
Favorite | TC[WOS]:19 TC[Scopus]:23  IF:6.7/6.2 | Submit date：2023/01/30
Ages/rage/akt/nrf2 Pathway  Diabetic Nephropathy  Huang-lian-jie-du Decoction  Metabolomics  Network Pharmacology  
A redox-sensitive and RAGE-targeting nanocarrier for hepatocellular carcinoma therapy Journal article
Fang X.-B., Xu Y.-Q., Chan H.-F., Wang C.-M., Zheng Q., Xiao F., Chen M.-W.. A redox-sensitive and RAGE-targeting nanocarrier for hepatocellular carcinoma therapy[J]. Molecular Pharmaceutics, 2016, 13(11), 3613-3625.
Authors:  Fang X.-B.;  Xu Y.-Q.;  Chan H.-F.;  Wang C.-M.;  Zheng Q.; et al.
Favorite | TC[WOS]:6 TC[Scopus]:7 | Submit date：2018/11/07
Hcc  Oridonin  Pluronic F68  Rage  Redox-sensitivity  
A Redox-Sensitive and RAGE-Targeting Nanocarrier for Hepatocellular Carcinoma Therapy. Journal article
Fang, X., Xu, Y., Chan, H.F., Wang, C., Zheng, Q., Xiao, F., Chen, M.. A Redox-Sensitive and RAGE-Targeting Nanocarrier for Hepatocellular Carcinoma Therapy.[J]. Molecular Pharmaceutics, 2016, 3613-3615.
Authors:  Fang, X.;  Xu, Y.;  Chan, H.F.;  Wang, C.;  Zheng, Q.; et al.
Favorite |   IF:4.5/4.6 | Submit date：2022/01/25
Hcc  Rage  Oridonin  Pluronic F68  Redox-sensitivity